DPRX: Dipexium Pharmaceuticals, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Dipexium Pharmaceuticals, Inc.

NASDAQ:DPRX

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$8.70
Loss Chance
58.4%
0.20JITTA SCORE
n/a
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Sorry, the data is not yet available for this stock.
Jitta Factors
Sorry, the data is not yet available for this stock.
Jitta Signs
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 7.99% in the last quarter (yoy)
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.20
n/a
3.14
96.79%
n/a
n/a
COMPANY DESCRIPTION
As of April 19, 2017, Dipexium Pharmaceuticals, Inc. was acquired by PLx Pharma, Inc. in a reverse merger transaction. Dipexium Pharmaceuticals, Inc., a late stage pharmaceutical company, focuses on the development and commercialization of antibiotics in the United States. The company develops Locilex (pexiganan cream 0.8%), a novel topical antibiotic for the treatment of mild infections of diabetic foot ulcers. Dipexium Pharmaceuticals, Inc. was founded in 2010 and is based in New York, New York.
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.